Title: The application of Marvelon dual suppression in patients with regular menstrual cycle during in vitro fertilization treatment
Abstract: Objective:To assess the application value of Marvelon dual suppression in patients with regular menstrual cycle during in vitro fertilization treatment.Methods:One hundred and seventy-two patients undergoing IVF-ET treatment were divided randomly into two groups.Eighty-six patients in the group A were pretreated with an oral contraceptive(Marvelon)for 21 days starting on the fifth day of menstruation 1.25 mg.Triptorelin was injected on the seventeenth day of Marvelon administration to achieve pituitary suppression.There were eithty-six patients in group B,who were detected by vaginal ultrasound scan one week after ovulation,1.25 mg Triptorelin was administrated without taking Marvelon.Gonadotrophin(Gn)was used from the third or fifth day of the next menstrual cycle in two groups.Results:Ovarian cyst developed in eight patients in the group B,and no patients in the group A.Six patients were cancelled for luteinizing unruptured follicle syndrome in group B,and one patient got pregnant after Triptorelin administration,but miscarriaged.There was significant difference between two groups in terms of pregnance rate,that was 39.5% vs 24.1%.Conclusion:Marvelon dual suppression in patients with regular menstrual cycle during in vitro fertilization treatment can add the endometrial thickness and promote pregnancy rate,abolishing ovarian cyst formation.
Publication Year: 2007
Publication Date: 2007-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot